| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Vesico-Ureteral Reflux | 39 | 2023 | 427 | 10.410 |
Why?
|
| Urinary Tract Infections | 22 | 2022 | 786 | 6.180 |
Why?
|
| Urology | 20 | 2023 | 397 | 5.820 |
Why?
|
| Urolithiasis | 12 | 2023 | 131 | 4.670 |
Why?
|
| Bladder Exstrophy | 12 | 2023 | 106 | 4.120 |
Why?
|
| Urologic Surgical Procedures | 23 | 2021 | 301 | 3.840 |
Why?
|
| Ureter | 13 | 2023 | 374 | 3.490 |
Why?
|
| Ureteroscopy | 12 | 2023 | 142 | 3.070 |
Why?
|
| Hydronephrosis | 8 | 2019 | 269 | 2.930 |
Why?
|
| Circumcision, Male | 9 | 2023 | 150 | 2.900 |
Why?
|
| Kidney Calculi | 9 | 2023 | 465 | 2.880 |
Why?
|
| Kidney Pelvis | 13 | 2018 | 188 | 2.730 |
Why?
|
| Urinary Bladder | 11 | 2023 | 1171 | 2.710 |
Why?
|
| Ureteral Obstruction | 11 | 2018 | 293 | 2.130 |
Why?
|
| Hypospadias | 9 | 2023 | 92 | 2.000 |
Why?
|
| Replantation | 6 | 2017 | 148 | 1.710 |
Why?
|
| Spermatic Cord Torsion | 3 | 2020 | 73 | 1.670 |
Why?
|
| Urography | 5 | 2016 | 313 | 1.640 |
Why?
|
| Spinal Dysraphism | 3 | 2023 | 160 | 1.580 |
Why?
|
| Cryptorchidism | 5 | 2023 | 123 | 1.540 |
Why?
|
| Urologic Diseases | 4 | 2019 | 244 | 1.410 |
Why?
|
| Urinary Tract | 3 | 2023 | 308 | 1.330 |
Why?
|
| Pediatrics | 10 | 2020 | 3462 | 1.300 |
Why?
|
| Antibiotic Prophylaxis | 7 | 2023 | 638 | 1.300 |
Why?
|
| Lithotripsy | 5 | 2012 | 143 | 1.300 |
Why?
|
| Cystinuria | 2 | 2020 | 19 | 1.300 |
Why?
|
| Infant | 68 | 2023 | 35070 | 1.290 |
Why?
|
| Child, Preschool | 71 | 2023 | 40955 | 1.290 |
Why?
|
| Child | 99 | 2023 | 77478 | 1.240 |
Why?
|
| Urethra | 5 | 2016 | 408 | 1.180 |
Why?
|
| Urologic Surgical Procedures, Male | 4 | 2017 | 75 | 1.180 |
Why?
|
| Fluoroscopy | 7 | 2021 | 924 | 1.130 |
Why?
|
| Urethral Stricture | 2 | 2017 | 51 | 1.070 |
Why?
|
| Urogenital Abnormalities | 4 | 2017 | 261 | 1.030 |
Why?
|
| Hospitals, Pediatric | 12 | 2021 | 1760 | 1.020 |
Why?
|
| Phimosis | 2 | 2023 | 10 | 0.960 |
Why?
|
| Urinary Incontinence | 4 | 2020 | 494 | 0.920 |
Why?
|
| Health Services Research | 3 | 2016 | 1834 | 0.920 |
Why?
|
| Ureteral Calculi | 2 | 2023 | 110 | 0.900 |
Why?
|
| Editorial Policies | 4 | 2020 | 451 | 0.880 |
Why?
|
| Ultrasonography, Prenatal | 4 | 2019 | 1694 | 0.850 |
Why?
|
| Diagnostic Techniques, Urological | 2 | 2012 | 28 | 0.840 |
Why?
|
| Dilatation, Pathologic | 3 | 2022 | 520 | 0.810 |
Why?
|
| Orchiectomy | 2 | 2021 | 466 | 0.810 |
Why?
|
| Male | 130 | 2023 | 349538 | 0.810 |
Why?
|
| Cerebral Palsy | 2 | 2023 | 459 | 0.800 |
Why?
|
| Genital Diseases, Female | 1 | 2023 | 197 | 0.800 |
Why?
|
| Gastrostomy | 2 | 2014 | 309 | 0.770 |
Why?
|
| Humans | 181 | 2023 | 742088 | 0.760 |
Why?
|
| Kidney | 9 | 2021 | 7167 | 0.760 |
Why?
|
| Radionuclide Imaging | 3 | 2021 | 2027 | 0.740 |
Why?
|
| Urinary Diversion | 2 | 2015 | 137 | 0.720 |
Why?
|
| Intermittent Urethral Catheterization | 1 | 2019 | 13 | 0.700 |
Why?
|
| Kidney Diseases | 2 | 2021 | 2145 | 0.660 |
Why?
|
| Publishing | 3 | 2020 | 833 | 0.660 |
Why?
|
| Evidence-Based Medicine | 3 | 2017 | 3611 | 0.650 |
Why?
|
| Medical Records | 2 | 2014 | 1413 | 0.650 |
Why?
|
| Urinary Bladder, Neurogenic | 3 | 2017 | 165 | 0.620 |
Why?
|
| Retrospective Studies | 50 | 2023 | 77098 | 0.620 |
Why?
|
| Enteral Nutrition | 2 | 2014 | 763 | 0.610 |
Why?
|
| Female | 99 | 2023 | 379592 | 0.600 |
Why?
|
| Adolescent | 51 | 2023 | 85649 | 0.600 |
Why?
|
| Cicatrix | 3 | 2020 | 761 | 0.590 |
Why?
|
| Epispadias | 3 | 2013 | 18 | 0.590 |
Why?
|
| Ultrasonography, Doppler | 1 | 2019 | 458 | 0.580 |
Why?
|
| Recurrence | 10 | 2021 | 8333 | 0.580 |
Why?
|
| Internet | 5 | 2016 | 3062 | 0.570 |
Why?
|
| Nephrolithiasis | 4 | 2022 | 110 | 0.570 |
Why?
|
| Laparoscopy | 7 | 2018 | 2121 | 0.570 |
Why?
|
| Dextrans | 2 | 2009 | 592 | 0.560 |
Why?
|
| Telemedicine | 6 | 2023 | 2853 | 0.560 |
Why?
|
| Prenatal Diagnosis | 4 | 2019 | 1232 | 0.550 |
Why?
|
| Penis | 6 | 2023 | 216 | 0.550 |
Why?
|
| Diurnal Enuresis | 1 | 2015 | 3 | 0.530 |
Why?
|
| Cystostomy | 1 | 2015 | 26 | 0.530 |
Why?
|
| Testicular Neoplasms | 1 | 2021 | 761 | 0.520 |
Why?
|
| Reading | 1 | 2019 | 557 | 0.520 |
Why?
|
| Acetaminophen | 1 | 2019 | 544 | 0.520 |
Why?
|
| Mass Screening | 5 | 2020 | 5238 | 0.510 |
Why?
|
| Urodynamics | 5 | 2020 | 347 | 0.510 |
Why?
|
| Nephrectomy | 4 | 2013 | 1049 | 0.510 |
Why?
|
| Infant, Newborn | 24 | 2020 | 25575 | 0.510 |
Why?
|
| Hyaluronic Acid | 2 | 2009 | 489 | 0.510 |
Why?
|
| Radiation Injuries | 2 | 2013 | 1178 | 0.510 |
Why?
|
| Periodicals as Topic | 3 | 2020 | 1431 | 0.500 |
Why?
|
| Postoperative Complications | 12 | 2022 | 15244 | 0.490 |
Why?
|
| Diabetes Complications | 2 | 2012 | 1359 | 0.480 |
Why?
|
| Appendix | 1 | 2015 | 110 | 0.480 |
Why?
|
| Specialties, Surgical | 1 | 2019 | 389 | 0.480 |
Why?
|
| Costs and Cost Analysis | 8 | 2020 | 1679 | 0.470 |
Why?
|
| Ureteroscopes | 2 | 2011 | 23 | 0.470 |
Why?
|
| Postoperative Care | 3 | 2020 | 1484 | 0.470 |
Why?
|
| Ultrasonography | 13 | 2021 | 5978 | 0.470 |
Why?
|
| Reperfusion Injury | 1 | 2020 | 1025 | 0.460 |
Why?
|
| Siblings | 2 | 2015 | 854 | 0.460 |
Why?
|
| Rural Health Services | 1 | 2017 | 379 | 0.460 |
Why?
|
| Urinary Fistula | 1 | 2013 | 41 | 0.450 |
Why?
|
| Social Participation | 1 | 2015 | 172 | 0.450 |
Why?
|
| Orchiopexy | 4 | 2023 | 20 | 0.450 |
Why?
|
| Cost-Benefit Analysis | 8 | 2016 | 5385 | 0.430 |
Why?
|
| Urination | 3 | 2021 | 204 | 0.430 |
Why?
|
| Information Dissemination | 2 | 2011 | 1100 | 0.410 |
Why?
|
| Sperm Injections, Intracytoplasmic | 1 | 2013 | 160 | 0.410 |
Why?
|
| Medical Informatics Applications | 1 | 2014 | 186 | 0.410 |
Why?
|
| Testis | 3 | 2020 | 800 | 0.390 |
Why?
|
| Societies, Medical | 3 | 2020 | 3740 | 0.390 |
Why?
|
| Radiation Dosage | 5 | 2021 | 1927 | 0.380 |
Why?
|
| Prune Belly Syndrome | 1 | 2010 | 5 | 0.380 |
Why?
|
| Diagnostic Imaging | 3 | 2015 | 3507 | 0.370 |
Why?
|
| Atlases as Topic | 1 | 2011 | 237 | 0.370 |
Why?
|
| Markov Chains | 2 | 2010 | 969 | 0.360 |
Why?
|
| Quality of Life | 6 | 2023 | 12730 | 0.360 |
Why?
|
| Ketorolac | 1 | 2010 | 77 | 0.350 |
Why?
|
| Health Facility Size | 2 | 2007 | 64 | 0.340 |
Why?
|
| Health Resources | 2 | 2013 | 911 | 0.340 |
Why?
|
| Incidence | 12 | 2019 | 20928 | 0.340 |
Why?
|
| Patient Satisfaction | 3 | 2012 | 3391 | 0.320 |
Why?
|
| Drug Resistance, Bacterial | 1 | 2016 | 1032 | 0.320 |
Why?
|
| Photography | 1 | 2011 | 521 | 0.320 |
Why?
|
| Cost of Illness | 2 | 2015 | 1852 | 0.320 |
Why?
|
| Observer Variation | 3 | 2019 | 2593 | 0.320 |
Why?
|
| Documentation | 1 | 2014 | 865 | 0.310 |
Why?
|
| Occupational Exposure | 1 | 2018 | 1794 | 0.310 |
Why?
|
| Prostate | 5 | 2003 | 1764 | 0.310 |
Why?
|
| Self Report | 2 | 2019 | 3548 | 0.300 |
Why?
|
| Follow-Up Studies | 14 | 2021 | 39004 | 0.300 |
Why?
|
| Reproducibility of Results | 9 | 2023 | 19862 | 0.290 |
Why?
|
| Colon | 1 | 2015 | 1773 | 0.290 |
Why?
|
| Fetal Diseases | 1 | 2012 | 903 | 0.290 |
Why?
|
| Ambulatory Surgical Procedures | 1 | 2011 | 454 | 0.290 |
Why?
|
| Obesity | 3 | 2015 | 12705 | 0.280 |
Why?
|
| United States | 25 | 2020 | 69693 | 0.280 |
Why?
|
| Nephrocalcinosis | 2 | 2017 | 48 | 0.280 |
Why?
|
| Ambulatory Care Facilities | 5 | 2022 | 932 | 0.280 |
Why?
|
| Prostatectomy | 4 | 2003 | 1871 | 0.280 |
Why?
|
| Technetium Tc 99m Dimercaptosuccinic Acid | 3 | 2021 | 79 | 0.270 |
Why?
|
| Penile Diseases | 1 | 2005 | 46 | 0.260 |
Why?
|
| Urinary Bladder Neck Obstruction | 1 | 2005 | 80 | 0.260 |
Why?
|
| Endoscopy | 3 | 2017 | 1774 | 0.260 |
Why?
|
| Kidney Neoplasms | 3 | 2011 | 4229 | 0.260 |
Why?
|
| Coitus | 1 | 2005 | 133 | 0.250 |
Why?
|
| Fertilization in Vitro | 1 | 2013 | 1284 | 0.250 |
Why?
|
| Guidelines as Topic | 1 | 2011 | 1402 | 0.250 |
Why?
|
| Glutathione Transferase | 3 | 2001 | 595 | 0.250 |
Why?
|
| Health Status | 2 | 2015 | 4030 | 0.250 |
Why?
|
| Health Education | 1 | 2011 | 1053 | 0.250 |
Why?
|
| Fever | 4 | 2021 | 1612 | 0.250 |
Why?
|
| Quality Improvement | 4 | 2020 | 3738 | 0.240 |
Why?
|
| Osteotomy | 2 | 2007 | 823 | 0.240 |
Why?
|
| Pelvic Bones | 1 | 2006 | 265 | 0.240 |
Why?
|
| Cystitis, Interstitial | 1 | 2004 | 61 | 0.240 |
Why?
|
| Decision Support Techniques | 3 | 2011 | 1952 | 0.240 |
Why?
|
| Genital Diseases, Male | 1 | 2004 | 83 | 0.240 |
Why?
|
| Severity of Illness Index | 5 | 2018 | 15530 | 0.240 |
Why?
|
| Disorders of Sex Development | 1 | 2004 | 122 | 0.230 |
Why?
|
| Scrotum | 1 | 2004 | 114 | 0.230 |
Why?
|
| Age Factors | 9 | 2019 | 18355 | 0.230 |
Why?
|
| Hospital Costs | 1 | 2010 | 980 | 0.230 |
Why?
|
| Time Factors | 12 | 2020 | 40054 | 0.230 |
Why?
|
| Secondary Prevention | 3 | 2021 | 1520 | 0.230 |
Why?
|
| Young Adult | 15 | 2021 | 56350 | 0.220 |
Why?
|
| Mouth Mucosa | 1 | 2005 | 434 | 0.220 |
Why?
|
| Robotics | 4 | 2013 | 892 | 0.220 |
Why?
|
| Lithotripsy, Laser | 1 | 2022 | 46 | 0.210 |
Why?
|
| Remission, Spontaneous | 3 | 2012 | 380 | 0.210 |
Why?
|
| Treatment Outcome | 17 | 2023 | 62966 | 0.210 |
Why?
|
| Pandemics | 3 | 2022 | 8328 | 0.210 |
Why?
|
| Peer Review, Research | 2 | 2022 | 329 | 0.210 |
Why?
|
| Oxalates | 1 | 2022 | 105 | 0.200 |
Why?
|
| Sufentanil | 1 | 2001 | 40 | 0.200 |
Why?
|
| Reflex | 1 | 2003 | 365 | 0.200 |
Why?
|
| Receptors, Purinergic P2 | 1 | 2022 | 152 | 0.200 |
Why?
|
| Hypertension | 2 | 2012 | 8455 | 0.200 |
Why?
|
| Family | 1 | 2012 | 3144 | 0.200 |
Why?
|
| Radiography | 4 | 2015 | 7010 | 0.200 |
Why?
|
| Reoperation | 6 | 2015 | 4200 | 0.190 |
Why?
|
| Decision Making | 1 | 2015 | 3869 | 0.190 |
Why?
|
| Angiomyolipoma | 1 | 2002 | 186 | 0.190 |
Why?
|
| Nocturnal Enuresis | 1 | 2020 | 12 | 0.190 |
Why?
|
| Cohort Studies | 11 | 2022 | 40450 | 0.190 |
Why?
|
| Abdominal Pain | 1 | 2007 | 1059 | 0.190 |
Why?
|
| Length of Stay | 3 | 2010 | 6294 | 0.190 |
Why?
|
| Cross-Sectional Studies | 8 | 2021 | 24913 | 0.190 |
Why?
|
| Biocompatible Materials | 1 | 2009 | 1731 | 0.190 |
Why?
|
| Risk Assessment | 4 | 2019 | 23320 | 0.190 |
Why?
|
| Tomography, X-Ray Computed | 5 | 2017 | 20086 | 0.190 |
Why?
|
| Multivariate Analysis | 6 | 2015 | 12242 | 0.190 |
Why?
|
| beta Carotene | 1 | 2022 | 527 | 0.190 |
Why?
|
| DNA Adducts | 1 | 2001 | 93 | 0.190 |
Why?
|
| Isoenzymes | 3 | 2001 | 1725 | 0.180 |
Why?
|
| Lasers, Solid-State | 1 | 2022 | 169 | 0.180 |
Why?
|
| Hospital Charges | 3 | 2007 | 362 | 0.180 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2010 | 2276 | 0.180 |
Why?
|
| Minority Groups | 1 | 2007 | 1215 | 0.180 |
Why?
|
| Probability | 2 | 2019 | 2502 | 0.170 |
Why?
|
| Anti-Bacterial Agents | 6 | 2022 | 7153 | 0.170 |
Why?
|
| Infant, Premature, Diseases | 1 | 2005 | 706 | 0.170 |
Why?
|
| Pregnancy | 6 | 2023 | 29087 | 0.170 |
Why?
|
| Calcium, Dietary | 1 | 2022 | 527 | 0.170 |
Why?
|
| Patient Education as Topic | 1 | 2009 | 2275 | 0.170 |
Why?
|
| Urinary Bladder, Overactive | 1 | 2020 | 106 | 0.170 |
Why?
|
| Feasibility Studies | 6 | 2020 | 5062 | 0.170 |
Why?
|
| Equipment and Supplies | 1 | 2001 | 281 | 0.170 |
Why?
|
| Risk Factors | 10 | 2022 | 72145 | 0.170 |
Why?
|
| Delivery of Health Care | 1 | 2017 | 5304 | 0.170 |
Why?
|
| Hydromorphone | 1 | 2019 | 65 | 0.160 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 2011 | 2229 | 0.160 |
Why?
|
| Stents | 1 | 2010 | 3276 | 0.160 |
Why?
|
| Parents | 2 | 2011 | 3387 | 0.160 |
Why?
|
| Hospitals | 4 | 2023 | 3937 | 0.160 |
Why?
|
| Analgesia, Patient-Controlled | 1 | 2019 | 109 | 0.160 |
Why?
|
| Carcinogens | 1 | 2001 | 466 | 0.160 |
Why?
|
| Anesthesia, Spinal | 1 | 2001 | 269 | 0.160 |
Why?
|
| Prospective Studies | 10 | 2019 | 53187 | 0.160 |
Why?
|
| Administration, Topical | 1 | 2020 | 688 | 0.160 |
Why?
|
| Case-Control Studies | 4 | 2022 | 21719 | 0.160 |
Why?
|
| Lidocaine | 1 | 2001 | 542 | 0.160 |
Why?
|
| Peer Review | 1 | 2020 | 208 | 0.150 |
Why?
|
| Potassium | 1 | 2022 | 1336 | 0.150 |
Why?
|
| Cystoscopy | 2 | 2011 | 134 | 0.150 |
Why?
|
| Body Mass Index | 1 | 2015 | 12695 | 0.150 |
Why?
|
| Lymphedema | 1 | 2004 | 528 | 0.150 |
Why?
|
| Delayed Diagnosis | 1 | 2021 | 438 | 0.150 |
Why?
|
| Postnatal Care | 1 | 2019 | 235 | 0.150 |
Why?
|
| Double-Blind Method | 4 | 2019 | 12017 | 0.150 |
Why?
|
| Nurse Practitioners | 1 | 2020 | 270 | 0.150 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2014 | 8925 | 0.150 |
Why?
|
| Electronic Health Records | 1 | 2014 | 4440 | 0.150 |
Why?
|
| Predictive Value of Tests | 5 | 2020 | 15056 | 0.150 |
Why?
|
| Pregnancy Trimester, Third | 1 | 2019 | 571 | 0.140 |
Why?
|
| Surgical Flaps | 1 | 2005 | 1634 | 0.140 |
Why?
|
| Atrophy | 2 | 2020 | 1576 | 0.140 |
Why?
|
| Monitoring, Intraoperative | 1 | 2003 | 953 | 0.140 |
Why?
|
| Injections, Intraperitoneal | 1 | 2017 | 424 | 0.140 |
Why?
|
| Healthcare Disparities | 1 | 2011 | 3151 | 0.140 |
Why?
|
| Intraoperative Period | 1 | 2017 | 520 | 0.130 |
Why?
|
| Prostate-Specific Antigen | 2 | 2003 | 2458 | 0.130 |
Why?
|
| Anion Transport Proteins | 1 | 2016 | 142 | 0.130 |
Why?
|
| Radiopharmaceuticals | 3 | 2021 | 2658 | 0.130 |
Why?
|
| Drug Industry | 1 | 2001 | 744 | 0.130 |
Why?
|
| Disease Management | 2 | 2016 | 2450 | 0.130 |
Why?
|
| Congresses as Topic | 1 | 2020 | 764 | 0.130 |
Why?
|
| Anesthetics | 1 | 2001 | 538 | 0.130 |
Why?
|
| Early Diagnosis | 3 | 2010 | 1184 | 0.130 |
Why?
|
| Urinary Incontinence, Urge | 1 | 2015 | 46 | 0.120 |
Why?
|
| Pyelonephritis | 2 | 2012 | 75 | 0.120 |
Why?
|
| Steroids | 1 | 2020 | 931 | 0.120 |
Why?
|
| Morphine | 1 | 2019 | 657 | 0.120 |
Why?
|
| Massachusetts | 3 | 2020 | 8662 | 0.120 |
Why?
|
| Anti-Infective Agents, Urinary | 1 | 2014 | 28 | 0.120 |
Why?
|
| Imidazoles | 1 | 2001 | 1205 | 0.120 |
Why?
|
| Pilot Projects | 3 | 2020 | 8297 | 0.120 |
Why?
|
| Perception | 1 | 2021 | 1188 | 0.120 |
Why?
|
| Conflict of Interest | 1 | 2019 | 542 | 0.120 |
Why?
|
| Sex Characteristics | 1 | 2004 | 2585 | 0.120 |
Why?
|
| Prostatic Neoplasms | 5 | 2003 | 11039 | 0.120 |
Why?
|
| Proportional Hazards Models | 3 | 2019 | 12344 | 0.120 |
Why?
|
| Diagnostic Errors | 1 | 2021 | 1255 | 0.110 |
Why?
|
| Abdominal Injuries | 1 | 2016 | 352 | 0.110 |
Why?
|
| Urinary Incontinence, Stress | 1 | 2015 | 183 | 0.110 |
Why?
|
| Databases, Factual | 4 | 2016 | 7716 | 0.110 |
Why?
|
| Adult | 21 | 2020 | 213712 | 0.110 |
Why?
|
| Clinical Protocols | 2 | 2017 | 1459 | 0.110 |
Why?
|
| Weight Loss | 1 | 2004 | 2604 | 0.110 |
Why?
|
| Odds Ratio | 2 | 2015 | 9846 | 0.110 |
Why?
|
| Adenocarcinoma | 4 | 2003 | 6347 | 0.110 |
Why?
|
| Practice Guidelines as Topic | 3 | 2019 | 7276 | 0.110 |
Why?
|
| Treatment Failure | 3 | 2007 | 2615 | 0.110 |
Why?
|
| Sex Factors | 2 | 2019 | 10392 | 0.110 |
Why?
|
| Factor Analysis, Statistical | 1 | 2015 | 975 | 0.110 |
Why?
|
| Patient Preference | 2 | 2016 | 886 | 0.100 |
Why?
|
| Comorbidity | 2 | 2020 | 10372 | 0.100 |
Why?
|
| Poisson Distribution | 1 | 2013 | 512 | 0.100 |
Why?
|
| Hemostasis, Surgical | 1 | 2012 | 128 | 0.100 |
Why?
|
| Electrocoagulation | 1 | 2012 | 158 | 0.100 |
Why?
|
| Models, Statistical | 2 | 2021 | 5100 | 0.100 |
Why?
|
| Anastomosis, Surgical | 1 | 2015 | 985 | 0.100 |
Why?
|
| Disease-Free Survival | 3 | 2012 | 6891 | 0.100 |
Why?
|
| Specialization | 1 | 2016 | 777 | 0.100 |
Why?
|
| Ischemia | 1 | 2020 | 1911 | 0.100 |
Why?
|
| Dose-Response Relationship, Radiation | 1 | 2013 | 876 | 0.100 |
Why?
|
| Fructose | 1 | 2013 | 288 | 0.100 |
Why?
|
| Hospitals, Teaching | 2 | 2007 | 1179 | 0.100 |
Why?
|
| Accidents, Traffic | 1 | 2016 | 819 | 0.100 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2020 | 1847 | 0.100 |
Why?
|
| Hospitalization | 2 | 2007 | 10232 | 0.100 |
Why?
|
| Publications | 1 | 2013 | 195 | 0.090 |
Why?
|
| Glucocorticoids | 1 | 2020 | 2107 | 0.090 |
Why?
|
| Consensus | 1 | 2019 | 2935 | 0.090 |
Why?
|
| Wounds, Nonpenetrating | 1 | 2016 | 794 | 0.090 |
Why?
|
| Nephrons | 1 | 2011 | 220 | 0.090 |
Why?
|
| Artificial Intelligence | 1 | 2023 | 2187 | 0.090 |
Why?
|
| Postoperative Period | 2 | 2006 | 1839 | 0.090 |
Why?
|
| Injections | 2 | 2010 | 840 | 0.090 |
Why?
|
| Morbidity | 1 | 2015 | 1767 | 0.090 |
Why?
|
| Disease Progression | 3 | 2023 | 13256 | 0.090 |
Why?
|
| Duodenum | 1 | 2012 | 483 | 0.090 |
Why?
|
| Surgical Wound Infection | 2 | 2011 | 1538 | 0.080 |
Why?
|
| Diagnosis, Differential | 3 | 2016 | 12958 | 0.080 |
Why?
|
| Pyridines | 1 | 2001 | 2818 | 0.080 |
Why?
|
| Decision Trees | 1 | 2010 | 506 | 0.080 |
Why?
|
| Calcium | 1 | 2022 | 5753 | 0.080 |
Why?
|
| Combined Modality Therapy | 1 | 2021 | 8621 | 0.080 |
Why?
|
| Patient Selection | 1 | 2020 | 4214 | 0.080 |
Why?
|
| Information Storage and Retrieval | 1 | 2014 | 824 | 0.080 |
Why?
|
| Boston | 2 | 2019 | 9305 | 0.080 |
Why?
|
| Age Distribution | 2 | 2016 | 2900 | 0.080 |
Why?
|
| Computer Simulation | 1 | 2021 | 6191 | 0.080 |
Why?
|
| Nomograms | 1 | 2009 | 224 | 0.080 |
Why?
|
| Emergencies | 1 | 2014 | 1164 | 0.070 |
Why?
|
| Recovery of Function | 1 | 2017 | 2924 | 0.070 |
Why?
|
| Kidney Function Tests | 1 | 2009 | 683 | 0.070 |
Why?
|
| Drug Utilization | 2 | 2011 | 1181 | 0.070 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2002 | 3123 | 0.070 |
Why?
|
| Kidney Calices | 1 | 2006 | 26 | 0.070 |
Why?
|
| Urinary Calculi | 1 | 2006 | 91 | 0.070 |
Why?
|
| Cultural Characteristics | 1 | 2007 | 262 | 0.070 |
Why?
|
| Psychometrics | 1 | 2015 | 2999 | 0.070 |
Why?
|
| Socioeconomic Factors | 3 | 2016 | 7770 | 0.070 |
Why?
|
| Middle Aged | 14 | 2016 | 213127 | 0.070 |
Why?
|
| Pregnancy Complications | 1 | 2019 | 2861 | 0.060 |
Why?
|
| Bone Nails | 1 | 2006 | 219 | 0.060 |
Why?
|
| Sensitivity and Specificity | 5 | 2020 | 14720 | 0.060 |
Why?
|
| Faculty, Medical | 1 | 2013 | 1182 | 0.060 |
Why?
|
| Prognosis | 4 | 2017 | 29010 | 0.060 |
Why?
|
| Intraoperative Complications | 1 | 2011 | 1188 | 0.060 |
Why?
|
| Urination Disorders | 1 | 2005 | 241 | 0.060 |
Why?
|
| Glutathione S-Transferase pi | 2 | 2001 | 97 | 0.060 |
Why?
|
| Tissue Expansion | 1 | 2005 | 162 | 0.060 |
Why?
|
| Potassium Chloride | 1 | 2004 | 238 | 0.060 |
Why?
|
| Diet | 1 | 2022 | 7923 | 0.060 |
Why?
|
| Genetic Markers | 2 | 2017 | 2633 | 0.060 |
Why?
|
| Diagnosis-Related Groups | 1 | 2005 | 454 | 0.060 |
Why?
|
| Leadership | 1 | 2013 | 1357 | 0.060 |
Why?
|
| Sex Distribution | 1 | 2008 | 2295 | 0.060 |
Why?
|
| Anticonvulsants | 1 | 2013 | 1914 | 0.060 |
Why?
|
| Chi-Square Distribution | 2 | 2010 | 3510 | 0.060 |
Why?
|
| Guideline Adherence | 2 | 2011 | 2266 | 0.060 |
Why?
|
| Multifactorial Inheritance | 1 | 2010 | 1190 | 0.060 |
Why?
|
| Equipment Design | 1 | 2011 | 3582 | 0.060 |
Why?
|
| Abbreviations as Topic | 1 | 2002 | 8 | 0.060 |
Why?
|
| Holmium | 1 | 2022 | 30 | 0.050 |
Why?
|
| Thulium | 1 | 2022 | 21 | 0.050 |
Why?
|
| Dermis | 1 | 2004 | 207 | 0.050 |
Why?
|
| Analgesics, Opioid | 1 | 2019 | 3667 | 0.050 |
Why?
|
| Tissue and Organ Harvesting | 1 | 2005 | 355 | 0.050 |
Why?
|
| Radiology | 1 | 2016 | 2090 | 0.050 |
Why?
|
| Calcium Oxalate | 1 | 2022 | 74 | 0.050 |
Why?
|
| Muscle Spasticity | 1 | 2023 | 154 | 0.050 |
Why?
|
| Mutation | 2 | 2017 | 29717 | 0.050 |
Why?
|
| Wound Healing | 1 | 2013 | 2781 | 0.050 |
Why?
|
| Osteomyelitis | 1 | 2006 | 402 | 0.050 |
Why?
|
| Thigh | 1 | 2003 | 247 | 0.050 |
Why?
|
| Pelvic Floor | 1 | 2003 | 138 | 0.050 |
Why?
|
| Prostatic Diseases | 1 | 2001 | 56 | 0.050 |
Why?
|
| Sodium Chloride | 1 | 2004 | 625 | 0.050 |
Why?
|
| Bone Transplantation | 1 | 2006 | 907 | 0.050 |
Why?
|
| Biotransformation | 1 | 2001 | 168 | 0.050 |
Why?
|
| Public Health | 1 | 2014 | 2594 | 0.050 |
Why?
|
| Ileum | 1 | 2003 | 565 | 0.050 |
Why?
|
| Forecasting | 1 | 2010 | 2948 | 0.050 |
Why?
|
| Gait | 1 | 2006 | 784 | 0.050 |
Why?
|
| Body Image | 1 | 2005 | 609 | 0.050 |
Why?
|
| Prostheses and Implants | 1 | 2007 | 1385 | 0.040 |
Why?
|
| Mutation, Missense | 2 | 2022 | 2556 | 0.040 |
Why?
|
| Pressure | 1 | 2003 | 1203 | 0.040 |
Why?
|
| General Surgery | 1 | 2011 | 1633 | 0.040 |
Why?
|
| Patient Compliance | 1 | 2010 | 2680 | 0.040 |
Why?
|
| Health Care Costs | 1 | 2013 | 3203 | 0.040 |
Why?
|
| Patient Transfer | 1 | 2005 | 760 | 0.040 |
Why?
|
| Absenteeism | 1 | 2020 | 250 | 0.040 |
Why?
|
| Chronic Disease | 1 | 2013 | 9144 | 0.040 |
Why?
|
| Muscle Contraction | 1 | 2003 | 1241 | 0.040 |
Why?
|
| Electric Stimulation | 1 | 2003 | 1770 | 0.040 |
Why?
|
| Neoplasm Staging | 2 | 2003 | 11001 | 0.040 |
Why?
|
| Precancerous Conditions | 2 | 2001 | 971 | 0.040 |
Why?
|
| Biopsy, Needle | 1 | 2003 | 1640 | 0.040 |
Why?
|
| Videoconferencing | 1 | 2020 | 195 | 0.040 |
Why?
|
| Cytosol | 1 | 2001 | 901 | 0.040 |
Why?
|
| Fibrosis | 1 | 2004 | 2026 | 0.040 |
Why?
|
| Universities | 1 | 2022 | 953 | 0.040 |
Why?
|
| Heredity | 1 | 2017 | 154 | 0.040 |
Why?
|
| Linear Models | 1 | 2007 | 5948 | 0.040 |
Why?
|
| Aged | 8 | 2003 | 162944 | 0.030 |
Why?
|
| Physical Examination | 1 | 2002 | 1239 | 0.030 |
Why?
|
| Attitude to Health | 1 | 2005 | 2051 | 0.030 |
Why?
|
| Radiographic Image Enhancement | 1 | 2021 | 885 | 0.030 |
Why?
|
| Animals | 2 | 2020 | 168561 | 0.030 |
Why?
|
| Lower Extremity | 1 | 2023 | 1151 | 0.030 |
Why?
|
| Sulfates | 1 | 2016 | 390 | 0.030 |
Why?
|
| Bicarbonates | 1 | 2016 | 313 | 0.030 |
Why?
|
| Surgery, Computer-Assisted | 1 | 2003 | 1009 | 0.030 |
Why?
|
| Logistic Models | 2 | 2010 | 13403 | 0.030 |
Why?
|
| Emergency Service, Hospital | 1 | 2014 | 7645 | 0.030 |
Why?
|
| Cost Savings | 1 | 2020 | 925 | 0.030 |
Why?
|
| Travel | 1 | 2020 | 788 | 0.030 |
Why?
|
| Oxidative Stress | 2 | 2001 | 3081 | 0.030 |
Why?
|
| Injury Severity Score | 1 | 2016 | 1013 | 0.030 |
Why?
|
| Obesity, Morbid | 1 | 2004 | 1204 | 0.030 |
Why?
|
| Glycosylation | 1 | 2016 | 1123 | 0.030 |
Why?
|
| Phantoms, Imaging | 1 | 2021 | 2466 | 0.030 |
Why?
|
| Immunoblotting | 1 | 2016 | 1683 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 1 | 2001 | 6313 | 0.030 |
Why?
|
| Embolization, Therapeutic | 1 | 2002 | 1392 | 0.030 |
Why?
|
| Transfection | 1 | 2001 | 5892 | 0.030 |
Why?
|
| Protein Folding | 1 | 2016 | 843 | 0.030 |
Why?
|
| Neoplasm Metastasis | 1 | 2003 | 4839 | 0.030 |
Why?
|
| Pain, Postoperative | 1 | 2002 | 1638 | 0.030 |
Why?
|
| Qualitative Research | 1 | 2020 | 2680 | 0.030 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2016 | 2505 | 0.030 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2016 | 2837 | 0.030 |
Why?
|
| Journal Impact Factor | 1 | 2013 | 156 | 0.030 |
Why?
|
| Prostatic Intraepithelial Neoplasia | 2 | 2001 | 76 | 0.030 |
Why?
|
| Ambulatory Care | 1 | 2022 | 2706 | 0.020 |
Why?
|
| Drug Resistance, Microbial | 1 | 2014 | 860 | 0.020 |
Why?
|
| Lipoproteins, LDL | 1 | 1994 | 628 | 0.020 |
Why?
|
| Age of Onset | 1 | 2017 | 3266 | 0.020 |
Why?
|
| Protein Transport | 1 | 2016 | 1988 | 0.020 |
Why?
|
| Health Services Accessibility | 1 | 2007 | 5133 | 0.020 |
Why?
|
| Pedigree | 1 | 2017 | 4646 | 0.020 |
Why?
|
| Perioperative Period | 1 | 2011 | 256 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2016 | 35342 | 0.020 |
Why?
|
| Reference Values | 1 | 2016 | 4982 | 0.020 |
Why?
|
| Medical Staff, Hospital | 1 | 2013 | 603 | 0.020 |
Why?
|
| Postoperative Hemorrhage | 1 | 2012 | 409 | 0.020 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2001 | 8425 | 0.020 |
Why?
|
| Protein Conformation | 1 | 2016 | 4013 | 0.020 |
Why?
|
| Genetic Association Studies | 1 | 2017 | 2699 | 0.020 |
Why?
|
| Aged, 80 and over | 2 | 2002 | 57683 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 1994 | 3862 | 0.020 |
Why?
|
| DNA | 1 | 2001 | 7289 | 0.020 |
Why?
|
| Algorithms | 2 | 2020 | 13853 | 0.020 |
Why?
|
| Autoantibodies | 1 | 1994 | 2036 | 0.020 |
Why?
|
| DNA Mutational Analysis | 1 | 2014 | 4187 | 0.020 |
Why?
|
| Unnecessary Procedures | 1 | 2008 | 431 | 0.020 |
Why?
|
| Program Evaluation | 1 | 2013 | 2485 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 2016 | 13814 | 0.010 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2016 | 3585 | 0.010 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2014 | 6534 | 0.010 |
Why?
|
| Immunoglobulin G | 1 | 1994 | 4554 | 0.010 |
Why?
|
| Lasers | 1 | 2006 | 952 | 0.010 |
Why?
|
| Prostatitis | 1 | 2001 | 102 | 0.010 |
Why?
|
| Catheterization | 1 | 2006 | 1468 | 0.010 |
Why?
|
| Drug Administration Schedule | 1 | 2008 | 4929 | 0.010 |
Why?
|
| Anticarcinogenic Agents | 1 | 2001 | 253 | 0.010 |
Why?
|
| Phenotype | 1 | 2017 | 16331 | 0.010 |
Why?
|
| Referral and Consultation | 1 | 2011 | 3527 | 0.010 |
Why?
|
| Quality of Health Care | 1 | 2013 | 4369 | 0.010 |
Why?
|
| CpG Islands | 1 | 2001 | 1170 | 0.010 |
Why?
|
| Biomedical Research | 1 | 2013 | 3306 | 0.010 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2001 | 1213 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2017 | 17400 | 0.010 |
Why?
|
| Thiobarbituric Acid Reactive Substances | 1 | 1994 | 46 | 0.010 |
Why?
|
| Buffers | 1 | 1994 | 147 | 0.010 |
Why?
|
| Malondialdehyde | 1 | 1994 | 104 | 0.010 |
Why?
|
| Antioxidants | 1 | 2001 | 1659 | 0.010 |
Why?
|
| Lipid Peroxidation | 1 | 1994 | 270 | 0.010 |
Why?
|
| Research Design | 1 | 2008 | 5979 | 0.010 |
Why?
|
| DNA Damage | 1 | 2001 | 2423 | 0.010 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2001 | 2940 | 0.010 |
Why?
|
| Serum Albumin | 1 | 1994 | 674 | 0.010 |
Why?
|
| Education, Medical, Graduate | 1 | 2002 | 2283 | 0.010 |
Why?
|
| Oxidation-Reduction | 1 | 1994 | 2187 | 0.010 |
Why?
|
| Antigens | 1 | 1994 | 1462 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2001 | 11363 | 0.000 |
Why?
|
| DNA Methylation | 1 | 2001 | 4282 | 0.000 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 1994 | 2099 | 0.000 |
Why?
|